Researchers have identified new blood and spinal fluid biomarkers that could help track ALS progression and monitor treatment ...
I wish I could shake the sadness I feel as my husband Todd’s caregiver after 15 years with ALS. There’s been a cloud over our lives since his diagnosis, even when his only physical symptom was a weak ...
Despite the inaccessibility of an "accessible" bathroom stall, columnist Dagmar Munn finds the humor in the situation.
The FDA has granted orphan drug status to the experimental T-cell, or Treg, therapy CK0803, being developed by Cellenkos to ...
ALS is more common in some parts of the U.S. than others and it has a very strong geographic association with MS, a new study ...
Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...
Diabetes was tied to a 3.3 times greater risk of earlier loss of walking ability in a study of amyotrophic lateral sclerosis ...
EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...
As her husband, Todd, celebrates his 55th birthday, columnist Kristin Neva reflects on what's changed since his diagnosis 15 years ago.
Life Time will host a nationwide fitness event Oct. 25 to raise funds for ALS research and children’s health. The annual GO90: Move with Meaning challenge will take place at Life Time locations ...
It took time for Philip to discover acceptance was key to him for living with ALS. Learn about his journey from diagnosis to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results